Anna completed her bachelor’s degree in 2010 at the University of Warsaw in Environmental Science. During the last year she spent six months on an Erasmus exchange at the University of Salford. Anna undertook her Master of Research degree in Medicinal Chemistry under the supervision of Prof A. Ganesan at the University of Southampton, working on the synthesis of analogues of Nelfinavir, graduating from the University of East Anglia in 2012. In October 2012 she started her PhD in the Brown Group working on modifying nucleic acids for therapeutic applications (a collaboration with GSK). After finishing her PhD she joined Illumina (Cambridge, UK).